1[1]Rose DK, Cohen MM, DoBoer DP. Cardiovascular events in the postanesthesia care unit. Contribution of risk factors.Anesthesiology, 1996,84: 772-781.
2[7]Nurmohamed MT, Buller HR, ten Cate JW. Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients. Drugs Aging,1994,5: 20-33.
3[8]van Gorp EC, Brandjes DP, ten Cate JW. Rational antithrombotic therapy and prophylaxis in elderly, immobile patients. Drugs Aging, 1998,13: 145-157.
4[11]Naesh O, Friis JT, Hindberg I, et al. Platelet function in surgical stress. Thromb Haemostas, 1985,54: 849-852.
5[15]Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol, 1983,1:940-945.
6[16]Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology,1998, 88:7-17.
8[18]Gaziano JM, Skerrett PJ, Buring JE. Aspirin in the treatment and prevention of cardiovascular disease. Haemostasis,2000,30(Suppl 3): 1-3.
9[19]Schwartz L, Bourassa M, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med,1988,318:1714-1719.
10[20]Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary bypass surgery and effects of antiplatelet therapy: result of a Veterans Administration Cooperative Study. Circulation, 1989, 80: 1190-1197.
